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Methods	  and	  methods   
 Following University of Michigan’s protocols, 4 healthy 
sheep (61±6.2 kg) were anesthetized. The left subclavian 
vessels were exposed surgically. Two vascular grafts were 
anastomosed to the artery and vein and subsequently 
cannulated (17Fr) to create an AV shunt. Each animal was 
extubated, recovered, and fitted with a low-resistance 
membrane gas exchanger. The device’s effectiveness at 
removing CO2 was measured by analyzing pre- and post-
device blood gases and sweep gas exhaust samples as room 
air sweep flow was incrementally raised from 0-15 L/min. 
This was done in awake, spontaneously breathing animals 
and repeated after they were re-anesthetized, placed on 
mechanical ventilation, and rendered hypercapnic by 
lowering minute ventilation to less than 2 L/min.  
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Conclusions	  
! !The arteriovenous shunt was 13.39±3.8% (21.2±2.5 
mL/min/kg) of cardiac output, yet systemic hemodynamics 
remained stable. Across the device, PaCO2 decreased on 
average from 28.6 to 19.3 mmHg in the healthy sheep, while in 
the hypercapnic animals it decreased from 59.4 to 36.2 mmHg. 
Device efficacy was further evidenced by the rising CO2 
removal rate for both animal conditions as the sweep flow 
increased, achieving a maximum of 228.25 mL/min in the 
healthy animals and 202.5 mL/min in the hypercapnic ones. 
This demonstrates that the proposed configuration is not only 
feasible, but has the potential to be a bridge to lung 
transplantation and even a future destination therapy for 
hypercapnic patients. 
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